Position
Pfizer Inc in Bolt Biotherapeutics, Inc.
Back to the book · All holders of BOLT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$34.1K$5.47 → $4.38
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 31.3K | $171.2K | — | — | — | 0.1% |
| Q1 2026 | 31.3K | $137.1K | $4.38 | −$34.1K | $0 | 0.1% |